52
Participants
Start Date
June 30, 2014
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Psychostimulants
"Participants will be tested twice 2 weeks apart. All will continue on their normal Psychostimulant dose up until 3 days before the testing day. 3 days before their 1st testing session, half the participants will start on either their current-dose of Psychostimulant or half their current dose depending on the arm they were randomized to (we provide those pills).~To control for different pharmacokinetics of the Psychostimulant medications, a given participant will be tested at roughly the peak time for his/her specific version of Psychostimulant and at the same time of day for his/her two testing sessions."
Developmental Cognitive Neuroscience Lab, Department of Psychiatry, University of British Columbia, Vancouver
University of British Columbia
OTHER